Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform.
Brambilla N, Morici N, Bedogni F, De Benedictis M, Scrocca I, Naldi M, Fiscella A, Prosperi F, Dominici M, Rebuzzi A, Colombo A, Sangiorgi GM; RISICO investigators. Brambilla N, et al. Among authors: naldi m. J Cardiovasc Med (Hagerstown). 2009 Nov;10(11):852-8. doi: 10.2459/JCM.0b013e32832e6446. J Cardiovasc Med (Hagerstown). 2009. PMID: 19550353
Safety and long-term efficacy of sirolimus eluting stent in ST-elevation acute myocardial infarction: the REAL (Registro REgionale AngiopLastiche Emilia-Romagna) registry.
Percoco G, Manari A, Guastaroba P, Campo G, Guiducci V, Aurier E, Sangiorgio P, Passerini F, Geraci G, Piovaccari G, Naldi M, Saia F, Marzocchi A; Real Investigators. Percoco G, et al. Among authors: naldi m. Cardiovasc Drugs Ther. 2006 Feb;20(1):63-8. doi: 10.1007/s10557-006-6753-9. Cardiovasc Drugs Ther. 2006. PMID: 16534548
Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an in vitro exploration.
Tubertini M, Menilli L, Milani C, Martini C, Navacchia ML, Nugnes M, Bartolini M, Naldi M, Tedesco D, Martella E, Guerrini A, Ferroni C, Moret F, Varchi G. Tubertini M, et al. Among authors: naldi m. Front Chem. 2024 Jun 18;12:1443822. doi: 10.3389/fchem.2024.1443822. eCollection 2024. Front Chem. 2024. PMID: 38957407 Free PMC article.
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance.
Sanese P, De Marco K, Lepore Signorile M, La Rocca F, Forte G, Latrofa M, Fasano C, Disciglio V, Di Nicola E, Pantaleo A, Bianco G, Spilotro V, Ferroni C, Tubertini M, Labarile N, De Marinis L, Armentano R, Gigante G, Lantone V, Lantone G, Naldi M, Bartolini M, Varchi G, Del Rio A, Grossi V, Simone C. Sanese P, et al. Among authors: naldi m. J Exp Clin Cancer Res. 2024 May 30;43(1):151. doi: 10.1186/s13046-024-03078-9. J Exp Clin Cancer Res. 2024. PMID: 38812026 Free PMC article.
118 results